Evolution of Therapeutic Antibodies, Influenza Virus Biology, Influenza, and Influenza Immunotherapy

This narrative review article summarizes past and current technologies for generating antibodies for passive immunization/immunotherapy. Contemporary DNA and protein technologies have facilitated the development of engineered therapeutic monoclonal antibodies in a variety of formats according to the...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	BioMed research international 2018-01, Vol.2018 (2018), p.1-23
Hauptverfasser:	Chaisri, Urai, Chaicumpa, Wanpen
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Annual precipitation Antibodies, Monoclonal Antibodies, Viral Antigens Avian flu B cells Bacterial infections Binding sites Biological evolution Biopharmaceutics Communicable diseases Deoxyribonucleic acid Disease control DNA Drug therapy Epidemics Hazardous materials Health aspects Hepatitis Humans Immune system Immunization Immunization (passive) Immunogenicity Immunoglobulins Immunology Immunotherapy Infections Influenza Influenza A Influenza A Virus, H1N1 Subtype Influenza Vaccines Influenza viruses Influenza, Human - immunology Influenza, Human - therapy Medical treatment Monoclonal antibodies Morbidity Orthomyxoviridae Infections Pandemics Precipitates Proteins Prototypes Rabies Review Technology application Thailand Vaccines Viral infections Virology Viruses
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!